The seroprevalence and salivary shedding of herpesviruses in Behçet's syndrome and recurrent aphthous stomatitis

Background Behçet's syndrome (BS) is one of the multisystemic diseases that presents with oral ulceration and several other systemic manifestations including genital ulceration, folliculitis, erythema nodosum-like lesions, uveitis, and arthropathy. Ocular manifestation, central nervous system involvement, and gastrointestinal manifestation account for most of the complications of this disease, whereas orogenital ulceration and dermatological involvement affects the quality of life. The cause of the disease is not fully elucidated; however, herpesviruses have long been thought to play a pivotal role in the disease pathogenesis. Objective To investigate the seroprevalence and salivary shedding of herpesviruses in BS. Method The levels of specific immunoglobulin G in six different herpesviruses in serum samples collected from 54 BS, 28 healthy controls (HC), and 7 recurrent aphthous stomatitis (RAS) patients were investigated. Salivary viral load was also quantified for these viruses in matched saliva samples using quantitative real-time polymerase chain reaction. Results The BS had lower cytomegalovirus (CMV) IgG level in comparison to HC (p=0.0226) and RAS (p=0.0450). There was statistically significant higher salivary shedding of Epstein-Barr virus (EBV) in BS in comparison to HC (p=0.0052), but not RAS (p=0.3318). Conclusions A high EBV shedding was observed in both BS and RAS and a lower level of CMV IgG was observed in BS only. The reason for the observed lower level of CMV IgG in BS is not clear. However, one explanation might be a defect in the cross-talk between innate and adaptive immune responses which was suggested by a previously described defect in the toll-like receptor 1 and 2 heterodimer formation and function, this being the initial receptor sensing of CMV.

[1]  L. Bergmeier,et al.  The role of TLR2 and 4 in Behçet's disease pathogenesis , 2014, Innate immunity.

[2]  G. Ramage,et al.  Commercial mouthwashes are ineffective against oral MRSA biofilms. , 2013, Oral surgery, oral medicine, oral pathology and oral radiology.

[3]  S. Tsao,et al.  The biology of EBV infection in human epithelial cells. , 2012, Seminars in cancer biology.

[4]  M. Wahlgren,et al.  Effect of Acute Plasmodium falciparum Malaria on Reactivation and Shedding of the Eight Human Herpes Viruses , 2011, PloS one.

[5]  D. Fuchs,et al.  Investigation of bacterial and viral agents and immune status in Behcet’s disease patients from Iran , 2011, International journal of rheumatic diseases.

[6]  D. Thorley-Lawson,et al.  The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output , 2009, PLoS pathogens.

[7]  R. Glaser,et al.  The EBV-Encoded dUTPase Activates NF-κB through the TLR2 and MyD88-Dependent Signaling Pathway1 , 2009, The Journal of Immunology.

[8]  Ruslan Medzhitov,et al.  Pattern recognition receptors and control of adaptive immunity , 2009, Immunological reviews.

[9]  C. Jones,et al.  The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. , 2009, Journal of immunology.

[10]  Y. Uyar,et al.  Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. , 2008, The new microbiologica.

[11]  H. Yazici,et al.  Mortality in Behçet's syndrome. , 2008, Clinical and experimental rheumatology.

[12]  A. Sher,et al.  Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.

[13]  A. Iwasaki,et al.  Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells , 2006, Proceedings of the National Academy of Sciences.

[14]  Eun-So Lee,et al.  Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet’s disease , 1996, Archives of Dermatological Research.

[15]  A. Burroughs,et al.  Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. , 2005, Journal of Infectious Diseases.

[16]  C. Evereklioglu,et al.  Managing the symptoms of Behçet’s disease , 2004, Expert opinion on pharmacotherapy.

[17]  E. Lee,et al.  Decreased serum level of antibody against human cytomegalovirus in patients with Behçet’s disease , 2003, Rheumatology International.

[18]  H. Er,et al.  Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. , 2002, Mediators of inflammation.

[19]  P. Pellett,et al.  Quantitative, Fluorogenic Probe PCR Assay for Detection of Human Herpesvirus 8 DNA in Clinical Specimens , 2001, Journal of Clinical Microbiology.

[20]  C. Chiang,et al.  Preliminary evidence for an association of Epstein-Barr virus with pre-ulcerative oral lesions in patients with recurrent aphthous ulcers or Behçet's disease. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[21]  N. Kitteringham,et al.  Use of the highly sensitive PCR method to detect the Herpes simplex virus type 1 genome and its expression in samples from Behçet disease patients. , 1998, Journal of medical and dental sciences.

[22]  C. Chiang,et al.  Human cytomegalovirus as a potential etiologic agent in recurrent aphthous ulcers and Behçet's disease. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[23]  E. Lennette,et al.  Characterization of Epstein‐Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriers , 1993, Journal of medical virology.

[24]  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. , 1990, Lancet.

[25]  A. Denman,et al.  Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. , 1988, British journal of rheumatology.

[26]  T. Lehner,et al.  DETECTION OF RNA COMPLEMENTARY TO HERPES-SIMPLEX VIRUS IN MONONUCLEAR CELLS FROM PATIENTS WITH BEHÇET'S SYNDROME AND RECURRENT ORAL ULCERS , 1982, The Lancet.

[27]  A. Denman,et al.  Lymphocyte abnormalities in Behçet's syndrome. , 1980, Clinical and experimental immunology.

[28]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[29]  Gray Gs The triple complex syndrome of Behcet. , 1950 .

[30]  G. Gray The triple complex syndrome of Behcet. , 1950, Canadian Medical Association journal.